Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Ha-Neui Kim to Aged

This is a "connection" page, showing publications Ha-Neui Kim has written about Aged.

 
Connection Strength
  
 
 
0.136
  
  1. Lee S, Kim IH, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Lee CS, Choi CS, Cho EY, Kim HC. Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients. Intervirology. 2010; 53(3):146-53.
    View in: PubMed
    Score: 0.034
  2. Choi CS, Cho EY, Park R, Kim SJ, Cho JH, Kim HC. X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma. J Med Virol. 2009 Oct; 81(10):1721-5.
    View in: PubMed
    Score: 0.033
  3. Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20; 35(36):4003-4011.
    View in: PubMed
    Score: 0.014
  4. Hirakawa M, Matos TR, Liu H, Koreth J, Kim HT, Paul NE, Murase K, Whangbo J, Alho AC, Nikiforow S, Cutler C, Ho VT, Armand P, Alyea EP, Antin JH, Blazar BR, Lacerda JF, Soiffer RJ, Ritz J. Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. JCI Insight. 2016 11 03; 1(18):e89278.
    View in: PubMed
    Score: 0.013
  5. Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016 Jul 14; 375(2):143-53.
    View in: PubMed
    Score: 0.013
  6. Cho EY, Kim HC, Choi CS, Shin SR, Park C, So HS, Kim HJ, Park R, Cho JH, Moon HB. Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients. Cancer Sci. 2010 Aug; 101(8):1905-12.
    View in: PubMed
    Score: 0.009
  7. Choi CS, Kim HC, Kim TH, Seo GS, Kim KH, Cho EY, Seo SO, Oh HJ, Choi SC. Does the endoscopic finding of esophageal metastatic hepatocellular carcinoma progress from submucosal mass to polypoid shape? Gastrointest Endosc. 2008 Jul; 68(1):155-9.
    View in: PubMed
    Score: 0.008
  8. Cho EY, Kim TH, Park SD, Yun KJ, Choi SC, Kim HC, Nah YH. Acral metastasis in a patient with ampullary carcinoma. Korean J Intern Med. 2007 Mar; 22(1):55-8.
    View in: PubMed
    Score: 0.007
  9. Cho JH, Park DS, Kim TH, Yeom JJ, Kim HC, Moon JH, Yang JS. [Genotypes of hepatitis B virus on Jeju island]. Korean J Hepatol. 2004 Mar; 10(1):42-50.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.